Book a Meeting

Anti-Phosphatidylserine Antibody, Highly Galactosylated (BioBet-GA-417ZP) (CAT#: BioBet-GA-417ZP) Datasheet

Target
Phosphatidylserine
Isotype
IgG1, κ
Description
Anti-Phosphatidylserine Antibody, Highly Galactosylated (BioBet-GA-417ZP) is a chimeric IgG1, κ antibody against Phosphatidylserine which contains with a high level of galactosylation.
Antibody Indication
Influenza
Classification
Therapeutic antibody; biobetter

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced Phosphatidylserine antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
Phosphatidylserine
Alternative Names
Bavituximab; 648904-28-3; ch3G4; PGN401; Phosphatidylserine; PS
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
IgG1, κ
Antibody Clone
BioBet-GA-417ZP
Host
Chimeric
Species Reactivity
Human
Description
The Highly Galactosylated Anti-Phosphatidylserine (Bavituximab), a biobetter antibody contains with a high level of galactosylation.
Antibody Indication
Influenza

Influenza

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK

Germany

ISO 9001 Certified - Creative Biolabs Quality Management System.